Publications by authors named "Mario G Cardozo"

Claim this Profile
O
Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2.
Guillaume Poncet-Montange, Yanai Zhan, Jennifer P Bardenhagen, Alessia Petrocchi, Elisabetta Leo, Mario G Cardozo

Biochem J· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors.
XianYun Jiao, David J Kopecky, JinSong Liu, JinQian Liu, Juan C Jaen, Mario G Cardozo

Bioorg Med Chem Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.
David J Kopecky, Xiaolin Hao, Yi Chen, Jiasheng Fu, XianYun Jiao, Mario G Cardozo

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent and selective PKC-theta inhibitors.
Charles L Cywin, Georg Dahmann, Anthony S Prokopowicz, Erick R R Young, Ronald L Magolda, Mario G Cardozo

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones: orally active inhibitors of lck kinase.
Daniel R Goldberg, Tanja Butz, Mario G Cardozo, Robert J Eckner, Abdelhakim Hammach

J Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-phenylamino-imidazo[4,5-h]isoquinolin-9-ones: a new class of inhibitors of lck kinase.
Roger J Snow, Mario G Cardozo, Tina M Morwick, Carl A Busacca, Yong Dong

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis